Registry Working Group Open Session

Size: px
Start display at page:

Download "Registry Working Group Open Session"

Transcription

1 Registry Working Group Open Session Chair: Irina Evseeva Chair elect: Annette Rasche Istanbul 20 th of March

2 Agenda Agenda item Time Topic Presenter Welcome and introduction Irina Evseeva New WMDA Standards discussion Pam Robinett Brief on Finance Project Timothy Fox Update on WMDA Handbook Annette Rasche Update on Search Coordinators Annette Rasche Certification Program Update on Forms Committee work Irina Evseeva AOB All

3 Towards new version of the WMDA standards, edition 2017 Advice requested from WMDA working groups Pam Robinett

4 WMDA Standards 17 th Edition proposals Registry mergers: policies and procedures Files transfers: validations Communications restricted to registry-to-registry Verify donor and recipient HLA at work-up Donor withdrawal consent 3 month time limit for results on search requests and associated payment

5 Registries Working Group New WMDA standard related to merging of two registries to one registry If, in case of a complete merging between two registries: The registry must have policies describing the transfer of the donor data There must be a written agreement between the transferring and accepting registry that describes the responsibilities of each entity The transferring registry must have a procedure to review the records of the transferred donor data The accepting registry must have a procedure to check the completeness and accuracy of the transferred donor data The accepting registry must ensure that the transferring registry complies with WMDA standards (according to the level of compliance of the accepting Registry)

6 Registries Working Group New WMDA standard related the transfer of donor/ cord blood file from a registry to another If all or part of a donor file is to be transferred to another registry, but the registry mantains its configuration: When transferring data from the registry to another body (BMDW, mirroring of data, etc) there should be a validated protocol for the transfer, both the transferring unit and the receiving unit must have policies to validate the data.

7 Registries Working Group New standard Where a national registry exist, all communications and all requests should/must go via the national registry. International registries/donor centres should/must not directly communicate with transplant centres in that country, unless specifically stated by the national registry.

8 Registries Working Group New standard At the point of donor work up the registry should have a process to check the HLA details for both patient and donor to ensure the request for this donor is valid.

9 Registries Working Group Revising standard 3.06 CURRENT WORDING: A volunteer donor must be free to withdraw at any time. REVISED WORDING: A volunteer donor must be free to withdraw at any time and must be informed of this ability and if appropriate the point at which this ethically can no longer occur.

10 Registries Working Group New standard The registry should report HLA typing results and/or additional information and/or an aliquot of donor (or maternal if cord blood) sample within a 3 month of the request. If results are provided after expiration of the 3 month period, the requesting registry need not guarantee payment of the services unless the requesting registry has previously confirmed the need for service completion despite the delay.

11 DRWG Open Session The cost of a cure: What is the value of a haematopoietic progenitor cell Donor Registry to a community? Timothy Fox, Anthony Nolan Amy Ronneberg, NMDP

12 Introduction to the research project Objectives Stimulus for the project A changing market, e.g. cost pressure, pricing disparity and real risk to the country registry, donor centre etc. Risks / opportunities posed by EU wide economic overview of the markets of stem cells for the European Commission (cost, pricing, market control) Project Aims Can the value a WMDA registry member provides to its own or other communities be quantified in a way that establishes an indispensable value above and beyond a crude assessment based on the price it charges for the provision of services and products?

13 Three phases of the Project 1. Project initiation and State of the Registry Economy 2. Defining the Registry business model (calculate an indicative / approximate cost of a Haematopoietic Progenitor Cell Unit (HPC Unit), considering all costs? and quantifying added value) 3. Financial benchmarks and cost saving opportunities

14 Phase 1 State of the registry economy Methodology: 16 registry interviews. Qualitative. Three broad questions: i. What will the market be like in 3 to 5 years? ii. Will members still be using the same business model to operate? iii. What do we need to do now as community if anything?

15 What will the market be like in 3 to 5 years? 1. More lives saved 2. The convergence of continuing clinical developments, increasing need for transplants, healthcare expenditure, better HLA typed donors, targeted and more efficient donor recruitment and IT developments will result in increasing competition between registries. 3. The current picture appears to be mixed dependent on the maturity of the registry, but the common theme is one of an increasing threat of protectionist policy in terms of competition.

16 What will the market be like in 3 to 5 years? 4. Real and increasing pressure on current and future funding. The necessary investment needed to improve efficiency, operational infrastructure and donor recruitment in order to compete. Both resulting in price and cost pressures. 5. Not only was it clear that there was a need for this research considering the changes to market over the last few years, but there is a real need to do something about it, quickly.

17 Will members still be using the same business model to operate? Emerging themes from Phase 1 include: 1. Collaboration or competition? 2. Increasing cost pressure and efficiencies may result in changes to registry infrastructure and survival 3. Investment decisions will be challenging in order to develop the registry, for example can or will a registry invest in IT, targeted recruitment, increasing the level of the HLA Typing resolution of existing donors, cord research etc.?

18 Will members still be using the same business model to operate? Emerging themes from Phase 1 include: 4. Review of strategy including, sustainable funding and pricing models 5. Prove value and efficiency. Clarity of funding and cost allocation.

19 What do we need to do now as community if anything? 1. Discuss openly (Internally efficiency, collaboration and sharing but maintain registries to support the diverse populations) 2. Commit to Phase 2: Cost of a Cure 3. Externally Consider the need to raise the profile of WMDA and members 4. Efficiency measures (short term?)

20 Next steps 1. Working Group to discuss Phase 1 findings and the Phase 2 approach. Phase 2 progress review in October Additional contributors required for phase 2 / 3: Contact: timothy.fox@anthonynolan.org: Research project outline Model / tool in development Phase 1 report

21 DRWG Open Session Handbook Committee Update Annette Rasche

22 WMDA Handbook: What s up? Thank you to Bruce Schmaltz! Welcome to Pam Robinett and Volker Rump Determine responsibles for Introduction and Glossary Training on new content management tool: WMDA Confluence platform Recap handbook update cycle for 2016 Version Evaluate idea of conducting a seminar for emerging registries

23 Handbook Project Members Introduction 1. General Organization of Registry Annette Rasche Beth Amer 2. Recruitment of Volunteer Donors Sabine Hildebrand Ann O Leary 3. Donor Search Request Gabi Rall Susie Joran 4. Collection and Transportation Michael Punzel Corina Gonzalez 5. Post Donation Grazia Nicoloso Maria MacWilliams 6. Cord Blood Banking Jacqueline Van Beckhoven Susana G. Gomez 7. Information Technology and data management David Steiner Ian Britton 8. Finance & Administration Volker Rump Carine Mijnarends Glossary

24 Handbook Review Cycle Working Cycle until August Edit Review September/October Cycle Post New Version on WMDA Confluenc e asap Close Edit Review Process End of the year Final Review November

25 DRWG Open Session Search Coordinators Certification Program Annette Rasche

26 Search Coordinators Certification Program: Basic Level Pilot Basic Level Pilot is running successful module 6 just started final exam will be scheduled evaluation by students for each module certificate must be designed, issued and distributed Evaluation of basic level materials is needed experts are welcome! students evaluation will be reflected

27 Search Coordinators Certification Program: Formal Basic Level Basic Level Program will be enrolled in fall Participation for the whole program with exam and certificate at the end or just for certain module(s) Fees proposed by WMDA board: Euro 100, per module for WMDA members Euro 200, per module for non members Euro 600, per year (whole course) for WMDA memb. Euro 1000, per year (whole course) for non members

28 Search Coordinators Certification Program: Advanced Level Pilot Modules 1 and 2. Umbilical cord blood unit selection Module 3. HLA mismatched donor is it always bad? Module 4. Aspects of graft selection Module 5. HLA nomenclature, HLA typing techniques Module 6. Advanced search strategy Modules 7 & 8. Case studies on donor search Module 9. IT tools for case study Speakers needed

29 Search Coordinators Certification Program: General Issues Terms & Conditions have to be defined. Help wanted! Clarification of Copyright issues. Help wanted! Potential collaboration with EBMT

30 DRWG Open Session Forms Committee Update Irina Evseeva, DRWG Chair

31 Thank you to Tom Wiegand! Welcome to Jennifer Wuchter

32 STATUS UPDATE SINCE NOVEMBER % of the forms updated with new WMDA logo Over 50% with content / functionality updates Updates to forms in progress anticipated release by Summer 2015 New forms proposed Proforma Invoice Notification of Donor Abnormal Findings Donor Not Cleared Form Change Control Document Form Functionality Testing

33 STATUS UPDATE SINCE NOVEMBER 2014 Change in Terminology: T Cell, Apheresis vs. MNC, Apheresis Development / Maintenance of Smart Forms Clarification statements being added to forms displaying decimal values

34 Thank you! FORMS COMMITTEE MEMBERS Mats Bengtsson Grazia Nicoloso Claudia Benkoe Gabi Rall Jason Dehn Annette Rasche Raewyn Fisher Jennifer Skinkle Kerri Heinen Ingrid Tistl Judith Maeck Anne Marie van Walraven Susanne Morsch Thomas Wiegand

35 Education Day 2015 Committee members: Betina Sorensen, Sabine Hildebrand, Elizabeth Murphy, Joannis Mytilineos, Michael Punzel, Grazia Nicoloso, Laurie Olesen, Irina Evseeva, Annette Rasche Survey of Education Day 2014: More time for discussions or questions Many suggestions on topics for Education Day 2015 Preliminary title: Registries Around the World Introduce World Café format: Make an interactive Education Day Cover more topics Meet new people Possibility to discuss in small groups and ask experts Encourage participants to bring a cases/problems/questions/challenges to be discussed in the World Cafe

Search Coordinator Certificate

Search Coordinator Certificate Educational. Expert led. E learning. Information and registration Educational. Expert led. E learning. Professionals involved in unrelated adult donor/cord blood unit search and selection are essential

More information

New Zealand Bone Marrow Donor Registry

New Zealand Bone Marrow Donor Registry Title: Authorised by: SECTION 9.0 NZBMDR STANDARDS PROCESS FOR AN UNRELATED STEM CELL DONOR WORKUP & IDENTIFICATION OF CORD BLOOD UNITS Executive Officer Contributing Authors: Sally Gordon Dr Hilary Blacklock

More information

The Danish Bone Marrow Donor Registry DBMDR

The Danish Bone Marrow Donor Registry DBMDR The DBMDR Vision To achieve and maintain a position as an internationally recognized hematopoietic stem cell donor registry with respect to high quality of donor data base and HLA typing, individualized,

More information

Title: SECTION 7.0 NZBMDR STANDARDS PROCESS FOR DONOR IDENTIFICATION

Title: SECTION 7.0 NZBMDR STANDARDS PROCESS FOR DONOR IDENTIFICATION NZBMDRGuidelines-007.10 Date Effective: 01/05/2010 Page 1 Title: SECTION 7.0 NZBMDR STANDARDS PROCESS FOR DONOR IDENTIFICATION Authorised by: Executive Officer Contributing Authors: ABMDR Scientific Expert

More information

Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science,

Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science, Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science, Lancaster University, UK Today Exploring Perceptions of 'Quality'

More information

EUROCORD. in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases

EUROCORD. in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases ! 21%! EUROCORD 6756 cord blood transplantations performed from 1988 to March 2010 in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases * missing center

More information

How To Be A Good Donor

How To Be A Good Donor 1 of 26 pages World Marrow Donor Association International Standards for Unrelated Hematopoietic Progenitor Cell Donor Registries Document Type: Standards WG/Committee: STDC World Document Reference: 20140101-STDC-

More information

A fact sheet UNRELATED BONE MARROW AND CORD BLOOD STEM CELL TRANSPLANTS

A fact sheet UNRELATED BONE MARROW AND CORD BLOOD STEM CELL TRANSPLANTS A fact sheet UNRELATED BONE MARROW AND CORD BLOOD STEM CELL TRANSPLANTS Each year, thousands of patients are diagnosed with diseases treatable by a blood stem cell transplant. These blood stem cells can

More information

Helping you find the one match.. Guide for Unrelated Stem Cell Transplant Patients OneMatch Stem Cell and Marrow Network BLOOD.

Helping you find the one match.. Guide for Unrelated Stem Cell Transplant Patients OneMatch Stem Cell and Marrow Network BLOOD. Helping you find the one match.. Guide for Unrelated Stem Cell Transplant Patients OneMatch Stem Cell and Marrow Network BLOOD.CA WWW This guide is intended for patients in need of an unrelated volunteer

More information

Inspection Guide for WMDA reviewers

Inspection Guide for WMDA reviewers WMDA Review and Inspection of Unrelated Volunteer Donor and Umbilical Cord Blood Registries Providing Hematopoietic Progenitor Cell to International Patients for WMDA Accreditation Guidelines for Reviewers

More information

Australian Bone Marrow Donor Registry PROTECTING YOUR PRIVACY OUR PRIVACY POLICY

Australian Bone Marrow Donor Registry PROTECTING YOUR PRIVACY OUR PRIVACY POLICY Australian Bone Marrow Donor Registry PROTECTING YOUR PRIVACY OUR PRIVACY POLICY WHO ARE WE? The Australian Bone Marrow Donor Registry (ABMDR) is a non-profit organisation that manages the processes of

More information

BMDW House Rules Date: April 5, 2013. Bone Marrow Donors Worldwide House Rules approval by the BMDW Editorial Board, April 5, 2013

BMDW House Rules Date: April 5, 2013. Bone Marrow Donors Worldwide House Rules approval by the BMDW Editorial Board, April 5, 2013 Bone Marrow Donors Worldwide House Rules approval by the BMDW Editorial Board, April 5, 2013 1. Definition Bone Marrow Donors Worldwide (BMDW) is an international service provided and managed by Europdonor

More information

hematopoietic stem cells from cord blood: - costless but too expensive? Dr. Vincent Kindler Geneva Cord Blood Bank HUG vincent.kindler@hcuge.

hematopoietic stem cells from cord blood: - costless but too expensive? Dr. Vincent Kindler Geneva Cord Blood Bank HUG vincent.kindler@hcuge. hematopoietic stem cells from cord blood: - costless but too expensive? Dr. Vincent Kindler Geneva Cord Blood Bank HUG vincent.kindler@hcuge.ch Spring water: Manufactured by nature COSTLESS Cord Blood:

More information

WMDA Activities Report 2014

WMDA Activities Report 2014 WMDA Activities Report 2014 www.wmda.info CONTENTS 2 Foreword by the WMDA President 2013 2014: William Hwang 4 Highlights of 2014 Planning of 2015 6 Activities of the WMDA Board Committees Accreditation

More information

5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.

5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements. WMDA Policy Statement for the Utility of Autologous or Family Cord Blood Unit Storage (This policy statement has been approved and adopted by the WMDA board on the 25 th of May 2006) The Cord Blood Registries

More information

CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION

CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION Chapter 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION 1.1 OVERVIEW OF THE CORD BLOOD TRANSPLANTATION STUDY Bone marrow transplantation

More information

14/11/2014. Law of 19 December 2008. MCH-MLM Bank E. BAUDOUX CHU LIEGE TRAINING DAY FOR SEARCH AND TRANSPLANT COORDINATORS 14 NOV 2014

14/11/2014. Law of 19 December 2008. MCH-MLM Bank E. BAUDOUX CHU LIEGE TRAINING DAY FOR SEARCH AND TRANSPLANT COORDINATORS 14 NOV 2014 TRAINING DAY FOR SEARCH AND TRANSPLANT COORDINATORS 14 NOV 2014 Going deeper into cell banking activities (including ATMPs) News from WMDA Fall meeting Law of 19 December 2008 Implementation of directives

More information

CBS National Public Cord Blood Bank. Did you donate your cord blood?

CBS National Public Cord Blood Bank. Did you donate your cord blood? CBS National Public Cord Blood Bank Did you donate your cord blood? Tanya Petraszko MD FRCPC October 2014 Overview What is a stem cell? The importance of HLA Need for cord blood stem cells For all Canadians

More information

4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.

4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements. WMDA Policy Statement on the Utility of Autologous or Family Cord Blood Unit Storage The WMDA Board adopted this policy on 25 th of May 2006. Policy updated _April 2011 The Cord Blood Working Group and

More information

NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript

NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript NIH Public Access Author Manuscript Published in final edited form as: Bone Marrow Transplant. 2010 May ; 45(5): 807 810. doi:10.1038/bmt.2010.10. The World Marrow Donor Association: Twenty Years of International

More information

Blood cells are vital to the human body

Blood cells are vital to the human body Candide FONT-SALA Blood cells are vital to the human body Red cells transport oxygen From http://www.english-online.at/biology/blood/blood-supply-and-blood-diseases.htm Red cell life span 120 days 200

More information

Use of the Global Registration Identifier for Donors [Data Structure 037]

Use of the Global Registration Identifier for Donors [Data Structure 037] IMPLEMENTATION GUIDE Use of the Global Registration Identifier for Donors [Data Structure 037] Version 1.0.0 September 2015 Tracking Number ICCBBA IG-038 Published by: ICCBBA in Collaboration with WMDA

More information

WMDA. Financial/Activities Report. www.wmda.info

WMDA. Financial/Activities Report. www.wmda.info WMDA Financial/Activities Report 2013 www.wmda.info CONTENTS 2 Foreword by the WMDA President: William Hwang 4 Highlights of 2013: Lydia Foeken 6 Activities of the WMDA Board Committees Board Budget Committee

More information

Economics of Cord Blood Banking. Michael Boo NMDP Be The Match September 11, 2015

Economics of Cord Blood Banking. Michael Boo NMDP Be The Match September 11, 2015 Economics of Cord Blood Banking Michael Boo NMDP Be The Match September 11, 2015 Historical Use UCB Use Data 2 NMDP Historical Transplants by Product 7,000 6,500 6,000 5,500 5,000 4,500 4,000 3,500 3,000

More information

Pros and Cons of Stem Cell Sources and their availability in Africa. Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa

Pros and Cons of Stem Cell Sources and their availability in Africa. Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa Pros and Cons of Stem Cell Sources and their availability in Africa Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa Introduction The ability to perform a haematopoietic stem

More information

RESOURCE. Medical Case Management Benchmarks. ING Re Industry Survey

RESOURCE. Medical Case Management Benchmarks. ING Re Industry Survey The following material was developed prior to RGA s acquisition on January 1, 2010 of the Group Reinsurance CLAIMS ADVISORY SERVICE IN THIS ISSUE: RESOURCE Reinsurance Outcomes and Service Experts VOLUME

More information

A Public Cord Blood Bank for South Africa? i

A Public Cord Blood Bank for South Africa? i No. 42/2007 A Public Cord Blood Bank for South Africa? i By Dr Robert Crookes MBChB (Wits), Dip. Internal Medicine (American Board of Internal Medicine, USA) Transfusion Medicine Consultant. South African

More information

Q: Why is there a need for people to join the Be The Match Registry?

Q: Why is there a need for people to join the Be The Match Registry? Q: Why is there a need for people to join the Be The Match Registry? A: Thousands of patients with blood cancers like leukemia and lymphoma, sickle cell and other life-threatening diseases depend on the

More information

JAN 2 3 2015. umbilical cord blood stem cell transplants is growing rapidly in. the State of Hawaii, specifically amongst ethnic minority

JAN 2 3 2015. umbilical cord blood stem cell transplants is growing rapidly in. the State of Hawaii, specifically amongst ethnic minority S.B. NO.FW JAN 0 A BILL FOR AN ACT THE SENATE TWENTY-EIGHTH LEGISLATURE, 0 STATE OF HAWAII RELATING TO UMBILICAL CORD BLOOD DONATION. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: 0 SECTION.

More information

YOU RE A POTENTIAL MATCH

YOU RE A POTENTIAL MATCH YOU RE A POTENTIAL MATCH Explore the Journey to Donation Edward, PBSC donor, with his wife, Andrea TABLE OF CONTENTS A patient needs you You re a potential match and next steps 3 Steps of the donation

More information

Equality of Access to Transplant for Ethnic Minority Patients Through Use of Cord Blood and Haploidentical Transplants

Equality of Access to Transplant for Ethnic Minority Patients Through Use of Cord Blood and Haploidentical Transplants Equality of Access to Transplant for Ethnic Minority Patients Through Use of Cord Blood and Haploidentical Transplants Lown R.N., 1 Marsh S.G.E., 1 Blake H., 1 Evseeva I., 1 MacKinnon, S., 2 Pagliuca,

More information

Cord blood banking: information for parents

Cord blood banking: information for parents Cord blood banking: information for parents Published August 2006 by the RCOG Contents Page number Key points 1 About this information 2 What is cord blood? 2 Why is cord blood useful? 3 How is cord blood

More information

Canadian Blood Services National Public Cord Blood Bank Give Life Twice Transfusion Medicine Residents

Canadian Blood Services National Public Cord Blood Bank Give Life Twice Transfusion Medicine Residents Canadian Blood Services National Public Cord Blood Bank Give Life Twice Transfusion Medicine Residents Eileen Quinlan Collection Supervisor, Brampton (GTA) 2015-11-10 History One Match Stem Cell and Marrow

More information

A Guide To Cord Blood Banking

A Guide To Cord Blood Banking A Guide To Cord Blood Banking For Families with Genetic Conditions Cord Blood Banking This leaflet is aimed at families who might be considering storing cord blood for the treatment of a child or other

More information

Be the One to Save a Life: Partnerships with Be The Match. Melinda Caltabiano

Be the One to Save a Life: Partnerships with Be The Match. Melinda Caltabiano Be the One to Save a Life: Partnerships with Be The Match Melinda Caltabiano Awesome Video https://www.youtube.com/watch?v=l0md h9p4ry0&list=uumudnzf2lklmlkuw_yxqe ha The NATIONAL MARROW DONOR PROGRAM

More information

2. TRansport ARRANGEMENTS... 5 2.1. Flight arrangements... 5 2.2. Ground transport arrangements... 5

2. TRansport ARRANGEMENTS... 5 2.1. Flight arrangements... 5 2.2. Ground transport arrangements... 5 World Marrow Donor Association (WMDA) Guidelines for couriers and the transportation of haematopoietic progenitor cells (HPC-BM, apheresis and therapeutic cells- T Cells) 1. COURIERS... 3 1.1. Courier

More information

Stem Cell Transplantation and the Canadian First Nations Community. Becky Luk (PTLS) Tanya Petraszko, MD

Stem Cell Transplantation and the Canadian First Nations Community. Becky Luk (PTLS) Tanya Petraszko, MD Stem Cell Transplantation and the Canadian First Nations Community Becky Luk (PTLS) Tanya Petraszko, MD Why is there a need for stem cells? Our Story Why are we engaging the First Nations, Metis and Inuit

More information

How to select a donor and product for allogeneic HCT

How to select a donor and product for allogeneic HCT How to select a donor and product for allogeneic HCT Dr Bronwen Shaw 10 February 2015 Overview Who (and where) are the donors What factors determine how we choose between them Acquisition Clinical Donor

More information

Donate your baby s cord blood and save lives.

Donate your baby s cord blood and save lives. Donate your baby s cord blood and save lives. A public nonprofit cord blood bank licensed by the FDA Each year, thousands of people are diagnosed with life-threatening diseases that may be cured with a

More information

Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape

Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape GENReports: Market & Tech Analysis Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape > Enal Razvi, Ph.D. Biotechnology Analyst, Managing Director SELECTBIO US enal@selectbio.us

More information

Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris

Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris Background Hematopoietic stem cell transplantation (HSCT) is

More information

International NetCord Foundation Executive Committee Conference Call Minutes May 23, 2007

International NetCord Foundation Executive Committee Conference Call Minutes May 23, 2007 International NetCord Foundation Executive Committee Conference Call Minutes Committee Members: Board Members: Staff: President Joan Garcia and Drs. Yves Beguin and Elizabeth Shpall Drs. Cristina Navarrete

More information

Program Report to the Advisory Council on Blood Stem Cell Transplantation. Shelley Grant September 11, 2015

Program Report to the Advisory Council on Blood Stem Cell Transplantation. Shelley Grant September 11, 2015 Program Report to the Advisory Council on Blood Stem Cell Transplantation Shelley Grant September 11, 2015 Presentation Overview Review legislative authority for Stem Cell Therapeutic and Research Reauthorization

More information

Page 1 of 6 Bill Analysis @ www.senate.michigan.gov/sfa sb1353etal./0506 STEM CELL BLOOD BANKS S.B. 1353 & 1354 & H.B. 6291-6295: COMMITTEE SUMMARY

Page 1 of 6 Bill Analysis @ www.senate.michigan.gov/sfa sb1353etal./0506 STEM CELL BLOOD BANKS S.B. 1353 & 1354 & H.B. 6291-6295: COMMITTEE SUMMARY STEM CELL BLOOD BANKS S.B. 1353 & 1354 & H.B. 6291-6295: COMMITTEE SUMMARY Senate Bills 1353 and 1354 (as introduced 6-29-06) House Bill 6291 (Substitute H-2 as passed by the House) House Bill 6292 (Substitute

More information

Guide to Regulatory Requirements for the Procurement of Human Tissues and Cells intended for Human Application

Guide to Regulatory Requirements for the Procurement of Human Tissues and Cells intended for Human Application Guide to Regulatory Requirements for the Procurement of Human Tissues and Cells intended for Human AUT-G0102-1 3 JANUARY 2013 This guide does not purport to be an interpretation of law and/or regulations

More information

Outcome of Unrelated HSCT in Patients Lacking HLA Matched Related Donors: Iranian Stem Cell Donor Program (ISCDP)

Outcome of Unrelated HSCT in Patients Lacking HLA Matched Related Donors: Iranian Stem Cell Donor Program (ISCDP) Outcome of Unrelated HSCT in Patients Lacking HLA Matched Related Donors: Iranian Stem Cell Donor Program (ISCDP) October 18, 2014 19th Congress of APBMT, Hangzhou, China AMIR ALI HAMIDIEH, MD Iranian

More information

The future of unrelated Stem Cell Transplant in the UK: DOH Working Party Findings. Prof. Tony Pagliuca

The future of unrelated Stem Cell Transplant in the UK: DOH Working Party Findings. Prof. Tony Pagliuca The future of unrelated Stem Cell Transplant in the UK: DOH Working Party Findings Prof. Tony Pagliuca UK STEM CELL STRATEGIC FORUM The future of unrelated donor SCT in the UK Antonio Pagliuca, Transplant

More information

HELP SAVE A LIFE DONATE YOUR CORD BLOOD

HELP SAVE A LIFE DONATE YOUR CORD BLOOD HELP SAVE A LIFE DONATE YOUR CORD BLOOD University Hospitals of Leicester Anthony Nolan Cord Blood Donation Programme Did you know that following the safe birth of your baby, you could save a person s

More information

Jeffrey W. Chell, M.D.

Jeffrey W. Chell, M.D. Jeffrey W. Chell, M.D. Management Experience 2000 Present National Marrow Donor Program Minneapolis, MN Chief Executive Officer Facilitates over 6,000 Bone Marrow and Stem Cell transplants between volunteer

More information

Canadian Blood Services National Public Cord Blood Bank

Canadian Blood Services National Public Cord Blood Bank Canadian Blood Services National Public Cord Blood Bank Dr. Heidi Elmoazzen Director, National Public Cord Blood Bank Hematopoetic Stem Cells Hematopoetic stem cells are not yet mature (undifferentiated)

More information

ETHICS GUIDE FCT INVESTIGATOR PROGRAMME. 25 July 2013

ETHICS GUIDE FCT INVESTIGATOR PROGRAMME. 25 July 2013 ETHICS GUIDE FCT INVESTIGATOR PROGRAMME 25 July 2013 ETHICAL ISSUES Ethics is central to scientific integrity, honesty and clarity of science. It is considered essential by FCT in the research activities

More information

umbilical cord blood banking A guide for parents

umbilical cord blood banking A guide for parents umbilical cord blood banking A guide for parents 2 nd Edition 2016 This guide has been elaborated by the Council of Europe European Committee on Organ Transplantation (CD-P-TO). For more information, please

More information

SAVE A LIFE... BY GIVING LIFE!

SAVE A LIFE... BY GIVING LIFE! SAVE A LIFE... BY GIVING LIFE! FOLLOW US ON: HÉMA-QUÉBEC PUBLIC CORD BLOOD BANK www.hema-quebec.qc.ca Scan this code with your smart phone to access the page Register to the Public Cord Blood Bank on the

More information

Improving Quality in Cellular Therapy with FACT Accreditation. The Foundation for the Accreditation of Cellular Therapy

Improving Quality in Cellular Therapy with FACT Accreditation. The Foundation for the Accreditation of Cellular Therapy Improving Quality in Cellular Therapy with FACT Accreditation The Foundation for the Accreditation of Cellular Therapy 1 Goals and Services of FACT Promote quality patient care and laboratory practice

More information

ANTHONY NOLAN SEARCH ALGORITHM FOR A BASIC CORD BLOOD UNIT SELECTION BY SERGIO QUEROL AND IRINA EVSEEVA FEBRUARY 2012

ANTHONY NOLAN SEARCH ALGORITHM FOR A BASIC CORD BLOOD UNIT SELECTION BY SERGIO QUEROL AND IRINA EVSEEVA FEBRUARY 2012 ANTHONY NOLAN SEARCH ALGORITHM FOR A BASIC CORD BLOOD UNIT SELECTION BY SERGIO QUEROL AND IRINA EVSEEVA FEBRUARY 2012 PAGE 1 OF 7 PRINCIPLES FOR A NEW ALGORITHM Once cord blood transplantation (CBT) is

More information

SEARCHING FOR A BONE MARROW DONOR

SEARCHING FOR A BONE MARROW DONOR SEARCHING FOR A BONE MARROW DONOR Angela received a bone marrow transplant from an unrelated donor to treat her non-hodgkin s lymphoma. INFORMATION FOR PATIENTS AND THEIR FAMILIES For patients who need

More information

Cord Blood Bank Business Plan

Cord Blood Bank Business Plan Cord Blood Bank Business Plan A sample of how to create a new program Produced by the AABB subsection: Cellular Therapy Business Management with major contributions by Nicole Omer TABLE OF CONTENTS Page

More information

Product Complaint Form Instructions

Product Complaint Form Instructions Product Complaint Form Instructions Note: Product Complaint Definition: Failure/possible failure of a drug (includes biological products) to meet any of its specifications. This includes complaints that

More information

General Information about Donating Blood Stem Cells

General Information about Donating Blood Stem Cells General Information about Donating Blood Stem Cells This document contains general information about joining the national Registry and donating blood stem cells. You could be the Questions & Answers Paul

More information

UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE

UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE HIND AL HUMAIDAN, MD,FRCPA Director, Blood Bank (Donor & Transfusion Services) and Stem Cell Cord Blood Bank Consultant Hematopathologist INTRODUCTION

More information

GAO NATIONAL CORD BLOOD INVENTORY. Practices for Increasing Availability for Transplants and Related Challenges. Report to Congressional Committees

GAO NATIONAL CORD BLOOD INVENTORY. Practices for Increasing Availability for Transplants and Related Challenges. Report to Congressional Committees GAO United States Government Accountability Office Report to Congressional Committees October 2011 NATIONAL CORD BLOOD INVENTORY Practices for Increasing Availability for Transplants and Related Challenges

More information

UMBILICAL CORD BLOOD BANKING A guide for parents

UMBILICAL CORD BLOOD BANKING A guide for parents UMBILICAL CORD BLOOD BANKING A guide for parents 2 nd EDITION INTRODUCTION The cells contained in the umbilical cord blood have therapeutic value for the treatment of blood disorders and immune diseases.

More information

Transmedcon 2014. Ahmedabad, Gujarat November 14-16, 2014

Transmedcon 2014. Ahmedabad, Gujarat November 14-16, 2014 FACT Accreditation for Cord Blood Banks and Cellular Therapy Nadim Mahmud, MD, PhD Associate Professor of Medicine Division of Hematology/Oncology Director, Hospital Stem Cell Laboratory Blood & Marrow

More information

The Cord Blood Industry and Be The Match

The Cord Blood Industry and Be The Match The Cord Blood Industry and Be The Match Arthur Busse Manager of Business Analytics NMDP: Be The Match Sept. 11, 2015 Be The Match Mission Saving Lives with cellular therapy through science, service and

More information

10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program. Thursday, June 7

10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program. Thursday, June 7 10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program Thursday, June 7 7:00 8:00 AM Breakfast in Exhibit Hall Session IA 8:00 10:00 AM Advances in

More information

Summary of Act for Appropriate Provision of Hematopoietic Stem Cells to be Used in Transplantations

Summary of Act for Appropriate Provision of Hematopoietic Stem Cells to be Used in Transplantations Summary of Act for Appropriate Provision of Hematopoietic Stem Cells to be Used in Transplantations Basic principles are established and the responsibilities of the national government are clarified in

More information

Table of Contents. FACT Quality Handbook, Second Edition. Table of Contents

Table of Contents. FACT Quality Handbook, Second Edition. Table of Contents Table of Contents INTRODUCTION... i ACKNOWLEDGEMENTS... ii 1. Quality Management Program Overview... 1 Diagram of Quality Program Elements... 9 Sample Quality Management Performance Summary: Colorado Blood

More information

Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease

Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease 1 Produced by St. Jude Children s Research Hospital Departments of Hematology, Patient

More information

Using Cost Effectiveness Analysis to Determine Inventory Size for a National Umbilical Cord Blood Bank

Using Cost Effectiveness Analysis to Determine Inventory Size for a National Umbilical Cord Blood Bank Using Cost Effectiveness Analysis to Determine Inventory Size for a National Umbilical Cord Blood Bank Martin Maiers, Bioinformatics National Marrow Donor Program, USA NMDP Minneapolis, MN, USA NATIONAL

More information

By: Senators Shafer of the 48th, Staton of the 18th, Thomas of the 54th, Rogers of the 21st, Heath of the 31st and others AN ACT

By: Senators Shafer of the 48th, Staton of the 18th, Thomas of the 54th, Rogers of the 21st, Heath of the 31st and others AN ACT 07 SB148/AP Senate Bill 148 By: Senators Shafer of the 48th, Staton of the 18th, Thomas of the 54th, Rogers of the 21st, Heath of the 31st and others AS PASSED AN ACT To amend Title 31 of the Official

More information

Summary of Advisory Council on Blood Stem Cell Transplantation: Recommendations and Status

Summary of Advisory Council on Blood Stem Cell Transplantation: Recommendations and Status of Advisory Council on Blood Stem Cell Transplantation: Recommendations and Shelley Grant Branch Chief, Blood Stem Cell Transplantation Program September 11, 2015 Overview December 20, 2005 - HRSA began

More information

S. 681 IN THE SENATE OF THE UNITED STATES

S. 681 IN THE SENATE OF THE UNITED STATES II TH CONGRESS 1ST SESSION S. 1 To amend the Public Health Service Act to establish a National Cord Blood Stem Cell Bank Network to prepare, store, and distribute human umbilical cord blood stem cells

More information

German Standards for Unrelated Blood Stem Cell Donations

German Standards for Unrelated Blood Stem Cell Donations ZKRD Zentrales Knochenmarkspender-Register Deutschland Phone: E-Mail: Secretary: -000 secretary@zkrd.de Postfach 4244, 89032 Ulm STS: -200 sts@zkrd.de Phone: +49 731 1507-000 Accounting: -300 finance@zkrd.de

More information

International NetCord Foundation Executive Committee Conference Call Minutes September 10, 2014

International NetCord Foundation Executive Committee Conference Call Minutes September 10, 2014 International NetCord Foundation Executive Committee Conference Call Minutes September 10, 2014 Committee Members: Staff: President Etienne Baudoux and Drs. Gesine Koegler, Joanne Kurtzberg and Alexander

More information

Public Cord Blood Tissue Bank Committee on Health Care Services and Representative Peaden

Public Cord Blood Tissue Bank Committee on Health Care Services and Representative Peaden HOUSE OF REPRESENTATIVES COMMITTEE ON HEALTH CARE SERVICES ANALYSIS BILL #: HB 2337 (PCB HCS 00-07) RELATING TO: SPONSOR(S): TIED BILL(S): Public Cord Blood Tissue Bank Committee on Health Care Services

More information

Flow cytometric analysis of stem cells derived from umbilical cord blood CD34+/CD45+ enumeration and viability

Flow cytometric analysis of stem cells derived from umbilical cord blood CD34+/CD45+ enumeration and viability Flow cytometric analysis of stem cells derived from umbilical cord blood CD34+/CD45+ enumeration and viability Doretha Thompson Dissertation in fulfillment of the requirements for the degree Magister Scientiae

More information

OPERATIONS USER GUIDE

OPERATIONS USER GUIDE OPERATIONS USER GUIDE 1 Ver 1.3 (06/12) CONTENTS 1 Background and organisation of Anthony Nolan 3 2 Patients for whom a search may be requested 5 3 Procedure for requesting HLA testing and a search 6 4

More information

Cord blood donation is a painless and free gesture, helping others and saving lives.

Cord blood donation is a painless and free gesture, helping others and saving lives. Cord blood donation is a painless and free gesture, helping others and saving lives. Cord blood, a bond for life. GRANDE CAUSE NATIONALE 2009 Donation for scientific research If your donation does not

More information

Annual Report 2006. The Norwegian Bone Marrow Donor Registry

Annual Report 2006. The Norwegian Bone Marrow Donor Registry Annual Report The Norwegian Bone Marrow Donor Registry ANNUAL REPORT THE NORWEGIAN BONE MARROW DONOR REGISTRY The Norwegian Bone Marrow Donor Registry (NBMDR) was established in 199 at the Institute of

More information

cord blood 4-1-1230, Off Abids Road, Bogulkunta, Hyderabad 500001. 3-6-282, Opp. Old MLA Qrtrs., Hyderguda, Hyderabad 500029.

cord blood 4-1-1230, Off Abids Road, Bogulkunta, Hyderabad 500001. 3-6-282, Opp. Old MLA Qrtrs., Hyderguda, Hyderabad 500029. Department of Obstetrics cord blood UNIT 1 BOGULKUNTA 4-1-1230, Off Abids Road, Bogulkunta, Hyderabad 500001. UNIT 2 HYDERGUDA 3-6-282, Opp. Old MLA Qrtrs., Hyderguda, Hyderabad 500029. UNIT 3 JUBILEE

More information

Cord Blood Advisory Group: Organization and Highlights (from November 2013 meeting)

Cord Blood Advisory Group: Organization and Highlights (from November 2013 meeting) Cord Blood Advisory Group: Organization and Highlights (from November 2013 meeting) Presented to the AABB Center for Cellular Therapies Cord Blood subsection by Merry Duffy Director, Cord Blood Operations,

More information

Public Cord Blood Banking at the National Cord Blood Program (NCBP)

Public Cord Blood Banking at the National Cord Blood Program (NCBP) Public Cord Blood Banking at the National Cord Blood Program (NCBP) A. Scaradavou, MD Medical Director, National Cord Blood Program, New York Blood Center Associate Attending, Pediatric BMT Memorial Sloan-Kettering

More information

Deciding quality surrounding umbilical cord blood treatments in Japan and the UK

Deciding quality surrounding umbilical cord blood treatments in Japan and the UK TG04 Expert Decision-Making in the Face of Uncertainty: The Influence of Organisational, Inter-Personal and Professional Factors Deciding quality surrounding umbilical cord blood treatments in Japan and

More information

Policies and Procedures

Policies and Procedures NHS Blood and Transplant Policies and Procedures Information Charter [POL13] 2 Policy Reference Title Approved by This document replaces version issued June 2008 [POL13] NHSBT Information Charter Information

More information

Corporate Medical Policy Cord Blood as a Source of Stem Cells

Corporate Medical Policy Cord Blood as a Source of Stem Cells Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description

More information

Overview of OneMatch, including the OneMatch Public Cord Blood Bank

Overview of OneMatch, including the OneMatch Public Cord Blood Bank Overview of OneMatch, including the OneMatch Public Cord Blood Bank Dr. Heidi Elmoazzen, Director OneMatch Public Cord Bank 2012-09-27 Outline Overview and Introduction Overview of the need for stem cells

More information

SAVING LIVES: ACHIEVING MORE

SAVING LIVES: ACHIEVING MORE SAVING LIVES: ACHIEVING MORE Anthony Nolan Organisational strategy for 2015-2018 Where we re coming from In 1974, we were the world s first stem cell donor register. And over 40 years later, we re at the

More information

Background: 1) Does your center have effective ways of collecting data from multiple sources to submit to multiple organizations?

Background: 1) Does your center have effective ways of collecting data from multiple sources to submit to multiple organizations? University of Michigan Best Practices Pam James, MS CCRP Administrative Manager, Data Management Bone Marrow Transplant, Hematologic Malignancies & NCCN Background: The data management team at the University

More information

»medical programs and services. transfusion medicine fellowship program

»medical programs and services. transfusion medicine fellowship program »medical programs and services transfusion medicine fellowship program new york blood center transfusion medicine fellowship program» Experience at one of the largest nonprofit, community-based blood centers

More information

Global Glossary of Terms and Definitions on Donation and Transplantation

Global Glossary of Terms and Definitions on Donation and Transplantation Global Glossary of Terms and Definitions on Donation and Transplantation Geneva, November 2009 1 2 Global Glossary of terms and definitions on donation and transplantation The lack of a globally recognized

More information

User Guide for Practice Managers

User Guide for Practice Managers Healthcare Identifiers Service User Guide for Practice Managers Designed to assist practice managers to implement the Healthcare Identifiers (HI) Service. PAGE A This publication was produced by the National

More information

The Infinite Potential of Stem Cell Japan s Cord Blood Bank and Transplant

The Infinite Potential of Stem Cell Japan s Cord Blood Bank and Transplant The Infinite Potential of Stem Cell Japan s Cord Blood Bank and Transplant Speech by Dr. Tsuneo A. Takahashi Translated by Stella Wang Japan and the United States are the two most experienced countries

More information

Directed/Related Cord Blood Collection by NHS Blood and Transplant

Directed/Related Cord Blood Collection by NHS Blood and Transplant Directed/Related Cord Blood Collection by Jacqui Thompson Clinical Scientist Section Head of Specialist Procedures Stem Cells and Immunotherapies Department National Blood Service, NHSBT Birmingham Why

More information

Cord Blood/Cord Tissue Storage Agreement

Cord Blood/Cord Tissue Storage Agreement Cord Blood/Cord Tissue Storage Agreement The following definitions are used in this Agreement: child sample you/your SCI/us/we your child from whose umbilical cord the Sample is taken; the sample of cord

More information

Corporate Medical Policy Cord Blood as a Source of Stem Cells

Corporate Medical Policy Cord Blood as a Source of Stem Cells Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description

More information

Umbilical Cord Blood Transplantation

Umbilical Cord Blood Transplantation Umbilical Cord Blood Transplantation V Rocha MD, PhD Hopital Saint Louis, Paris University 7 CIBMTR Milwaukee Umbilical Cord blood transplantation Background History Clinical results in children and adults

More information

Donation of Umbilical Cord Blood. A precious life offer. for everyone!

Donation of Umbilical Cord Blood. A precious life offer. for everyone! Donation of Umbilical Cord Blood A precious life offer for everyone! Donation of Umbilical Cord Blood A precious life offer for everyone! Page 3 Hellenic Cord Blood Bank Page 4 Haematopoietic Progenitor

More information

42 USC 274k. NB: This unofficial compilation of the U.S. Code is current as of Jan. 4, 2012 (see http://www.law.cornell.edu/uscode/uscprint.html).

42 USC 274k. NB: This unofficial compilation of the U.S. Code is current as of Jan. 4, 2012 (see http://www.law.cornell.edu/uscode/uscprint.html). TITLE 42 - THE PUBLIC HEALTH AND WELFARE CHAPTER 6A - PUBLIC HEALTH SERVICE SUBCHAPTER II - GENERAL POWERS AND DUTIES Part I - C.W. Bill Young Cell Transplantation Program 274k. National Program (a) Establishment

More information

2015 FCT INVESTIGATOR GRANTS GUIDE ON ETHICAL ISSUES

2015 FCT INVESTIGATOR GRANTS GUIDE ON ETHICAL ISSUES 2015 FCT INVESTIGATOR GRANTS GUIDE ON ETHICAL ISSUES GUIDE ON ETHICAL ISSUES Ethics is central to scientific integrity, honesty and clarity of science. It is considered essential by the FCT in the research

More information

11/10/2011. History of CBUs. 10-CBA providing access to unlicensed cord blood units. The FDA s involvement. The FDA s involvement, cont.

11/10/2011. History of CBUs. 10-CBA providing access to unlicensed cord blood units. The FDA s involvement. The FDA s involvement, cont. History of CBUs First CBU transplant done in 1988 10-CBA providing access to unlicensed cord blood units Using the NMDP IND to access unlicensed cord blood units Amy Hays, Sr. Clinical Research Specialist,

More information